Tech Company Financing Transactions

Elephas Biosciences Funding Round

Elephas Biosciences secured a $55 million Series C funding round on 1/23/2024. Investors included State of Wisconsin Investment Board, Venture Investors and Arch Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

918 Deming Way 201
Madison, WI 53717
USA

Phone

Undisclosed

Website

www.elephas.com

Email Address

Not Recorded

Overview

Elephas is solving this problem by developing an imaging platform technology to assess how live tumor fragments respond to cancer therapies. We are removing the trial-and-error approach to cancer care by harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence to accelerate drug development and empower clinical decision making.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Maneesh Arora

        

Chief Financial Officer

Terry Brady

        

Chief Scientific Officer

Jonathan Oliner

        

Vice President

Hinco Gierman

        

VP - Engineering

Pascual Starink

        

VP - Engineering

Mike Szulczewski

        

VP - Regulatory Affairs

Ann Leonard

        

Browse more venture capital transactions:

Prev: 1/23/2024: Neatleaf venture capital transaction
Next: 1/23/2024: GenEdit venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary